Core Scientific, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Core Scientific, Inc.'s yearly results (2022–2025), compared with Technology companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.5×Over the last 3 years its own operating cash paid for 45% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 71% of Technology companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Less steady than 66% of Technology companies in United States.
Growth Efficiency Ratio
—Sales fell 50%
Sales fell 50% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-50% / +191%In 3 years sales changed by -50% while total assets changed by +191%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
22.5×Debt due within a year is covered 22.5 times by its yearly operating cash.
Higher than 76% of Technology companies in United States.
Cash Cushion Ratio
−20%Debt, after subtracting cash, equals 20% of its market value (net debt).
Lower than 79% of Technology companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Core Scientific, Inc. made a loss over the last year. Core Scientific, Inc. owes $1.46 for every $1 it owns. Core Scientific, Inc. made a loss in each of the last two years.
Compared with Technology companies in United States · latest annual results Dec 2025.
P/E ratio
LossCore Scientific, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-1.74Core Scientific, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$4.2 BThe total market value of all of Core Scientific, Inc.'s shares at today's price (share price × number of shares), larger than 66% of Technology companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
NegativeCore Scientific, Inc.'s net worth is negative ($2.4 B below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.46×Core Scientific, Inc. owes $1.46 for every $1 it owns, so it owes more than it owns, higher than 97% of Technology companies in United States.
Dividend yield
NoneCore Scientific, Inc. does not currently pay a dividend.
Revenue growth
-38%Revenue fell 38% in the year to Dec 2025, and shrank 21% a year on average over 3 years.
Profit growth
LossCore Scientific, Inc. made a loss in each of the last two years.
Profit margin
-90.5%Core Scientific, Inc. lost $90 for every $100 of revenue.
Cash vs debt
Net debtCore Scientific, Inc. had $851 M more debt than cash (net debt) at Dec 2025.
Questions
How much does Core Scientific, Inc. owe compared with what it owns?
Core Scientific, Inc. owes $1.46 for every $1 it owns, so it owes more than it owns, higher than 97% of Technology companies in United States.
Does Core Scientific, Inc. pay a dividend?
No. Core Scientific, Inc. does not currently pay a dividend.
Is Core Scientific, Inc.'s revenue growing?
Revenue fell 38% in the year to Dec 2025, and shrank 21% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.